Millipore Sigma Vibrant Logo

481920 NAAG - CAS 3106-85-2 - Calbiochem

NAAG is a neuropeptide and a neurotransmitter that is abundant in the mammalian nervous system.

NAAG - CAS 3106-85-2 - Calbiochem : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: N-Acetyl-Asp-Glu, N-acetylaspartylglutamate; Spaglumic acid

View Products on Sigmaaldrich.com
481920
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
3106-85-2C₁₁H₁₆N₂O₈

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
481920-50MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Flacon en verre 50 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewNAAG is a neuropeptide and a neurotransmitter that is abundant in the mammalian nervous system. It remains uncertain whether this compound activates NMDA receptors; however, it is clearly demonstrated to act as a selective agonist of mGluR3, both in vitro and in vivo.
      Catalogue Number481920
      Brand Family Calbiochem®
      SynonymsN-Acetyl-Asp-Glu, N-acetylaspartylglutamate; Spaglumic acid
      References
      ReferencesNeale, J., et al. 2011. J. Neurochem. 12, in press; Neal, J., et al. 2011. J. Neurochem. 118, 490; Adedoyin, M., et al. 2010. Mol. Pain 6, 60; Chopra M., et al. 2009. J. Pharmacol. Exp. Ther. 330, 212; Fricker, A., et al. 2009. Neuropharmacology 56, 1060; Neale, J.,et al. 2005. Trends Pharmacol. Sci. 29, 477; Westbrook, G., et al. 1986. J. Neurosci. 11, 3385; Koller, K., et al. 1984. J. Neurochem. 43, 1136; Curatolo, A., et al. 1965, J. Neurochem. 12, 339.
      Product Information
      CAS number3106-85-2
      FormWhite powder
      Hill FormulaC₁₁H₁₆N₂O₈
      Chemical formulaC₁₁H₁₆N₂O₈
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by TLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Regulatory Review
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      481920-50MG 04055977225686

      Documentation

      NAAG - CAS 3106-85-2 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      NAAG - CAS 3106-85-2 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      481920

      Références bibliographiques

      Aperçu de la référence bibliographique
      Neale, J., et al. 2011. J. Neurochem. 12, in press; Neal, J., et al. 2011. J. Neurochem. 118, 490; Adedoyin, M., et al. 2010. Mol. Pain 6, 60; Chopra M., et al. 2009. J. Pharmacol. Exp. Ther. 330, 212; Fricker, A., et al. 2009. Neuropharmacology 56, 1060; Neale, J.,et al. 2005. Trends Pharmacol. Sci. 29, 477; Westbrook, G., et al. 1986. J. Neurosci. 11, 3385; Koller, K., et al. 1984. J. Neurochem. 43, 1136; Curatolo, A., et al. 1965, J. Neurochem. 12, 339.

      Brochure

      Titre
      Pathways and Biomarkers of Glutamatergic Synapse Flyer
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision03-April-2012 JSW
      SynonymsN-Acetyl-Asp-Glu, N-acetylaspartylglutamate; Spaglumic acid
      DescriptionNAAG is a neuropeptide and a neurotransmitter that is abundant in the mammalian nervous system. It remains uncertain whether this compound activates NMDA receptors; however, it is clearly demonstrated to act as a selective agonist of mGluR3, both in vitro and in vivo.
      FormWhite powder
      Intert gas (Yes/No) Packaged under inert gas
      CAS number3106-85-2
      Chemical formulaC₁₁H₁₆N₂O₈
      Structure formulaStructure formula
      Purity≥98% by TLC
      SolubilityDMSO (50 mg/ml) or Methanol (50 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Regulatory Review
      ReferencesNeale, J., et al. 2011. J. Neurochem. 12, in press; Neal, J., et al. 2011. J. Neurochem. 118, 490; Adedoyin, M., et al. 2010. Mol. Pain 6, 60; Chopra M., et al. 2009. J. Pharmacol. Exp. Ther. 330, 212; Fricker, A., et al. 2009. Neuropharmacology 56, 1060; Neale, J.,et al. 2005. Trends Pharmacol. Sci. 29, 477; Westbrook, G., et al. 1986. J. Neurosci. 11, 3385; Koller, K., et al. 1984. J. Neurochem. 43, 1136; Curatolo, A., et al. 1965, J. Neurochem. 12, 339.